
Sign up to save your podcasts
Or


Growing evidence shows that Alzheimer’s risk is shaped not only by genetics but also by culture, environment, and lifestyle — and researchers say these differences may hold the key to better prevention and treatment.Dr. Sid O’Bryant, professor of pharmacology and neuroscience at the University of North Texas, is the principal investigator of the Health & Aging Brain Study – Health Disparities (HABS-HD), the most comprehensive Alzheimer’s study ever conducted across African American, Hispanic, and non-Hispanic white communities. His approach brings research into diverse communities often left out of large-scale studies, ensuring that findings reflect the populations most at risk.In this conversation with Being Patient’s Mark Niu, O’Bryant explained how factors like diabetes, hypertension, environment, and even social support networks shape brain health. He explained that these findings show why Alzheimer’s cannot be treated with a “one size fits all” model. Instead, precision medicine — tailoring prevention and treatment strategies to an individual’s genetic, cultural, and lifestyle background — could transform how we approach brain health and Alzheimer's treatments.
What does it feel like to take part in the largest lifestyle intervention trial in the United States?In this conversation, Patty Kelly and Phyllis Jones share personal stories about how Alzheimer’s disease has shaped their families — and why they chose to get involved in groundbreaking research aimed at preventing or slowing cognitive decline.If you loved this video, visit our website to find more of our Alzheimer’s coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/
This Live Talk is produced by Being Patient with support provided by Cognito Therapeutics.
Learn more about Cognito's HOPE Study:https://www.hopestudyforad.com/
–
Researchers and technology companies are looking into whether non-invasive, non-drug therapies — like electromagnetic, visual, and auditory stimulation — can treat Alzheimer’s disease. So, what does the science say about these emerging therapies? What can they do for the brain?
Dr. Michelle Papka, founder and president of the Cognitive and Research Center of New Jersey (CRCNJ), joined Being Patient Live Talks to discuss emerging technology-assisted non-invasive interventions for Alzheimer’s.
Papka is a neuropsychologist, psychotherapist, and researcher with more than 30 years of combined experience working in aging, Alzheimer’s, and dementia, and her own private clinical practice in New Jersey. She’s also an active public speaker, invited editor, grant reviewer, consultant, and committee member of multiple specialized organizations and publications on aging and Alzheimer’s.
For over 15 years, she has served as the principal investigator on industry-sponsored clinical trials for Alzheimer’s disease and age-related cognitive impairment. Presently, she’s the principal investigator on Cognito’s HOPE study, which is testing the SPECTRIS AD device’s efficacy and safety for people living with Alzheimer’s, and an advisor to Cognito. This device uses visual and auditory stimulation to create gamma wave activity in the brain.
Listen to the live talk to learn her perspective on non-invasive interventions for Alzheimer’s disease and what the future may hold for these treatments.
This podcast is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly.
Precision medicine is a medical approach that considers a patient’s genes, environment, and lifestyle. In the realm of Alzheimer’s disease, experts are pushing for using this approach to improve diagnosis, treatment, and our understanding of the condition.
This video is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly.
This podcast is part of the Diversity + Dementia series, produced by Being Patient with support provided by Eisai inc.
Award-winning Alzheimer’s and dementia educator and best-selling author Dr. Macie P. Smith joined Being Patient Live Talks to discuss her latest book, “A Dementia Caregiver Called to Action: The Journey.” In the context of her experience as an educator and a licensed gerontology social worker, she’ll also speak to the caregiving needs specific to Black families and Black communities.
Alzheimer’s advocate Betsy Groves joined Being Patient Live Talks to discuss her long and rocky journey to an Alzheimer’s diagnosis, her experience living with Alzheimer’s, and her work advocating for other patients on this journey
Positive Approach to Care founder and dementia care expert Teepa Snow returns to Being Patient Live Talks for “Ask Teepa Anything” to answer Being Patient readers’ questions in real-time.
From the publisher's feed

2,030 Listeners

16 Listeners